Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Clinical diagnosis of radiation retinopathy.~2. Patients must be 18 years of age or older to receive treatment.~3. Visual acuity of 20/30 to 20/320 in study eye on the Early Treatment of Diabetic Retinopathy Study (ETDRS) visual acuity chart~4. Visual acuity of 20/800 or better in fellow eye on the ETDRS visual acuity chart.~Exclusion Criteria:~1. Patient with significantly compromised visual acuity in the study eye due to concomitant ocular conditions.~2. Patients who have undergone intraocular surgery within the last 2 months~3. Patient participating in any other investigational drug study.~4. Use of an investigational drug or treatment related or unrelated to their condition within 30 days prior to receipt of study medication.~5. Inability to obtain photographs to document choroidal neovascularization (CNV) (including difficulty with venous access)~6. Patient with significant liver disease or uremia.~7. Patient with known adverse reaction to fluorescein and indocyanine green or iodine.~8. Patient has a history of any medical condition which would preclude scheduled visits or completion of study~9. Patient has had insertion of scleral buckle in the study eye~10. Patient has received radiation treatment~11. Patient is on anticoagulant therapy with the exception of aspirin~12. Patient is pregnant or nursing.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).